• Postpone, perhaps avoid joint replacements

    Postpone, perhaps avoid joint replacements

    Last week, we traveled to Israel to celebrate the wedding of our youngest son. Israel became the destination for the event as Eric and Judith had met there while his music business was subcontracting to Coke and Judith led the International Marketing initiatives for Coke. The event took place on July...

    Read More

  • Regenerative options for patients receiving chemotherapy, immunosuppression or radiation therapy

    Regenerative options for patients receiving chemotherapy, immunosuppression or radiation therapy

    There has always been a category of patients for whom Bone Marrow Concentrate derived stem cells and growth factors were not a viable option. Patients who have received or are receiving chemotherapy, radiation therapy or immunosuppression have diminished stem cell viability and actual numbers. Such...

    Read More

  • Stem Cell Claims versus Outcomes Data

    Stem Cell Claims versus Outcomes Data

    It is now over four years since I began the most comprehensive outcomes clinical trial ever undertaken in which Bone Marrow Concentrate was used to reduce pain, improve function, increase activities and alter the progression of osteoarthritis in a knee joint. At the start, it was generally believed that...

    Read More

  • STEM CELLS

    STEM CELLS

    My clinical practice mission is to use autologous concentrated marrow-derived mononuclear cells for the care and treatment of a joint afflicted by degenerative arthritis so as to assist a patient in postponing, perhaps avoiding a joint replacement. I then follow the patient using osteoarthritis outcome...

    Read More

  • All Regenerative Physicians are Not the Same

    All Regenerative Physicians are Not the Same

    I am an orthopedic surgeon. The new focus for the arthritic joint is restoration and not replacement. Almost five years ago, I joined that emerging initiative after a 37-year professional career of having replaced joints. One of the recent problems emerging in this discipline of regenerative medicine...

    Read More

  • An exclusive interview with Interventional Orthopedic Surgical pioneer Mitchell Sheinkop, MD, (continued)

    An exclusive interview with Interventional Orthopedic Surgical pioneer Mitchell Sheinkop, MD, (continued)

    Blog: Dr. Sheinkop , let’s pick up where we ended at the last interview. You were going to tell us about the hip labrum? Sheinkop: Recently, there has been an increased frequency of diagnosis pertaining to an acetabular labral tear when a patient presents to a physician with groin pain. The cause may...

    Read More

  • Don’t be fooled by bogus stem cell claims

    Don’t be fooled by bogus stem cell claims

    When it comes to cellular orthopedics, for me, it is a matter of honor and self-interest. If you aren’t aware of the bogus stem cell claims or “false news”, read the LA Times article that appeared last week http://www.latimes.com/business/hiltzik/la-fi-hiltzik–oz-stem-cell-20170213-story.html...

    Read More

  • An exclusive Interview With Interventional Orthopedic Surgeon, Mitchell Sheinkop, MD

    An exclusive Interview With Interventional Orthopedic Surgeon, Mitchell Sheinkop, MD

    Blog: “Please explain Interventional Orthopedics?” Dr Sheinkop: “Five years ago, after 37 years of performing hip and knee replacements at a major medical center in Chicago, where I served as director of the Joint Replacement program, I exchanged the scalpel for a needle. Having achieved my surgical...

    Read More

  • On the results of injecting Bone Marrow Concentrate into the joint and into the adjacent bone for osteoarthritis

    On the results of injecting Bone Marrow Concentrate into the joint and into the adjacent bone for osteoarthritis

    Options for treating patients with osteoarthritis of their joints are historically limited to pain medication, anti-inflammatory medications, steroids, physical therapy, chiropractic care, or any combination thereof. These treatments provide temporary symptom relieving care, but do not offer therapeutic...

    Read More

  • Some Stem Cell Background Observations

    Some Stem Cell Background Observations

    There are approximately 2,500 Adult Mesenchymal Stem Cells per mL of Bone Marrow Concentrate on average according to the work of Dr. Phillipe Hernigou in Paris. It leads me to conclude that unconcentrated bone marrow aspirate doesn’t have enough MSCs per unit volume to contribute to a therapeutic potential...

    Read More

Back to top